Schoenherr has advised healthcare provider Mavie Next and its shareholder Mavie Holding, both part of the UNIQA Group, on Raiffeisen-Holding Niederosterreich-Wien’s planned investment of around EUR 100 million in Mavie Next. Dorda and BPV Huegel advised Raiffeisen-Holding NO-Wien. Heuking Kuehn Lueer Wojtek and Wardynski & Partners reportedly advised Raiffeisen-Holding NO-Wien as well.
According to Schoenherr, founded in 2020 as UNIQA’s corporate start-up, Mavie Next delivers corporate health services, telemedicine, home testing, and 24-hour care, and will deploy the funding to accelerate its expansion and innovation roadmap.
The Schoenherr team included Counsel Gregor Petric and Associate Maximilian Czernin.
The Dorda team included Managing Partner Francine Brogyanyi, Partners Christoph Brogyanyi, Martin Brodey, Tibor Varga, Stephan Steinhofer, Magdalena Brandstetter, Andreas Seling, and Nino Tlapak, Counsel Patricia Backhausen, Lawyers Elena Lanmueller, Florina Thenmayer, Julia Landskron, Lorenz Wicho, and Ulrich Weinstich, Associates Laura Colloredo-Mannsfeld, Thomas Krappinger, Vivien Lux, and Antonia Stubbe, and Legal Trainees Katja Ausweger and Julia Moser.
The BPV Huegel team includeed Partner Astrid Ablasser-Neuhuber and Senior Associate Philipp Stengg.